clinical trial · NCT07779616
Study of PTC844 in Participants With Active Rheumatoid Arthritis
Rheumatoid ArthritisPTC844Placebo
brief summary
This study is designed to assess the safety, pharmacokinetics (PK), and biomarker effects of PTC844 compared to placebo in participants with active rheumatoid arthritis (RA).
started
Sep 24, 2026
primary completion
Sep 30, 2027
completion
Oct 29, 2027
last updated
Nov 6, 2026
official title
A Phase 2A, Proof-of-Concept, Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PTC844 in Participants With Active Rheumatoid Arthritis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol